Zolmitriptan OD (zolmitriptan) NDC 59746-462

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-462Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0462Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59746-462-13	59746046213	1 BLISTER PACK in 1 CARTON (59746-462-13) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Sep 17, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zolmitriptan OD
Generic name (nonproprietary): zolmitriptan
Active ingredients: Zolmitriptan — 5 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Jubilant Cadista Pharmacuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202956
Marketing start: Sep 17, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 59746-462_5d9c2d59-8564-44d8-bd79-0e0b34ec50bdSPL ID 5d9c2d59-8564-44d8-bd79-0e0b34ec50bdSPL set ID a6a32fc6-4243-9cdd-91c7-b8a58e0f9811RxCUI 284201, 351134UNII 2FS66TH3YWUPC 0359746462130, 0359746461164
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746046213 followed by a unit qualifier and the quantity

Package 59746-0462-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2025.

Indications (excerpt from the label)

Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan orally disintegrating tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan orally disintegrating tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan orally disintegrating tablets are administered to treat any subsequent attacks. Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan orally disintegrating tablets have not been establishe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202956

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202956
Product	Strength	Form · route	Labeler	Product NDC
Zolmitriptan ODzolmitriptan	Zolmitriptan 2.5 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-998
Zolmitriptan ODzolmitriptan	Zolmitriptan 5 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-999
Zolmitriptan ODzolmitriptan	Zolmitriptan 2.5 mg/1	Tablet, Orally disintegratingOral	Jubilant Cadista Pharmacuticals Inc.	59746-461